Research Grant Program
The foundation provides research grants to support clinicians and scientists focused on primary immunodeficiency (PI).
The more you understand about primary immunodeficiency (PI), the better you can live with the disease or support others in your life with PI. Learn more about PI, including the various diagnoses and treatment options.
Living with primary immunodeficiency (PI) can be challenging, but you’re not alone—many people with PI lead full and active lives. With the right support and resources, you can, too.
Be a hero for those with PI. Change lives by promoting primary immunodeficiency (PI) awareness and taking action in your community through advocacy, donating, volunteering, or fundraising.
Whether you’re a clinician, researcher, or an individual with primary immunodeficiency (PI), IDF has resources to help you advance the field. Get details on surveys, grants, and clinical trials.
The foundation provides research grants to support clinicians and scientists focused on primary immunodeficiency (PI).
IDF’s Research Grant Program supports patient-centered research focused on improving the treatment, health, disease management, or diagnosis of people with PI, as well as research that contributes to the general body of PI knowledge.
The application deadline of June 30, 2025, has passed, and we are no longer accepting submissions for this year's research grant program. We will announce details about next year's research grant program, including application guidelines, deadlines, and funding opportunities, in early 2026. To be notified when the 2026 application period opens, please subscribe to our updates or check back on our website regularly.
Thank you for your interest in our research grant program.
IDF’s Research Committee, made up of recognized immunologists and past grant awardees, reviews and scores research proposals through a peer review process based on the system used by the National Institutes of Health (NIH). The committee recommends funding for the proposals with the highest scores, ensuring an unbiased and independent selection process based on scientific merit.
Applications for 2025 are now closed.
The application deadline of June 30, 2025, has passed, and we are no longer accepting submissions for this year's research grant program. Stay tuned for 2026.
2025’s four Research Grant Program awardees will use their funding to better understand some of the rarest primary immunodeficiencies (PIs) and develop diagnostics and treatments. Grantees are pictured from left to right, Drs. Eric Allenspach, Caroline Kuo, Ashley Lee, and Patrick O'Connell.
Starting in 2022, the top-ranked grant in each cycle has been awarded the Michael Blaese Research Grant Award, named in honor of the foundation's long-time medical advisor and noted PI researcher, Dr. Michael Blaese.
Blaese awardee: Dr. Eric Allenspach, Seattle Children’s Hospital.
Dr. Caroline Kuo, University of California, Los Angeles; Dr. Ashley Lee, Columbia University Irving Medical Center; Dr. Patrick O’Connell, Mount Sinai Kravis Children’s Hospital.
Blaese awardee: Dr. Emily Harris, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Dr. David Nguyen, University of California, San Francisco; Dr. Alexandra Martinson, Children's National Hospital; Dr. Lauren Meyer, Seattle Children’s Hospital.
Blaese awardee: Dr. Donald Kohn, University of California, Los Angeles.
Dr. Benjamin Solomon, Stanford University; Dr. Xiao Peng, Johns Hopkins University; Dr. Brynn O’Laughlin, Children’s National Hospital; Dr. Junghee Jenny Shin, Yale University.
Blaese awardee: Dr. Joud Hajjar, Baylor College of Medicine.
Dr. Brenna LaBere, Boston Children’s Hospital; Dr. Beth Thielen, University of Minnesota; Dr. Artemio Jongco, Feinstein Institutes of Medical Research.
Dr. Alice Chau, Seattle Children’s Institute; Dr. Pietro Genovese, Dana Farber Cancer Institute; Dr. Sarah Henrickson, Children's Hospital of Philadelphia; Dr. Michelle Hermiston, University of California San Francisco; Dr. Paul Maglione, Boston University School of Medicine; Dr. Bethany Percha, Icahn School of Medicine at Mount Sinai; Dr. Qian Zhang, The Rockefeller University.
Dr. Shanmuganathan Chandrakasan, Emory University; Dr. Stacey Lynn Clardy, University of Utah; Dr. Rui Yang, The Rockefeller University; Dr. Carolyn Baloh, Duke University.
Dr. Lori Broderick, University of California, San Diego; Dr. Megan Cooper, St. Louis Children’s Hospital Foundation; Dr. Attila Kumanovics, University of Utah; Dr. Carrie L. Lucas, Yale University.
Dr. Sara Barmettler, Massachusetts General Hospital; Dr. Nilesh Chitnis, Children's Hospital of Philadelphia; Dr. Joud Hajjar, Baylor School of Medicine; Dr. Artemio Jongco, Feinstein Institute for Medical Research; Dr. Sergio Rosenzweig, National Institutes of Health.
Dr. Sonia Sharma, La Jolla Institute for Allergy & Immunology.
In 2022, IDF sponsored a White Paper Challenge to seek out new ideas and address relevant topics in the PI community. We invited submissions from all individuals, institutions, schools, and researchers with exciting ideas about expanding awareness in communities of color, improving access to clinical trials, and shortening the time from diagnosis to treatment.
The IDF Survey Research Center provides current information on PI through the analysis of patient and caregiver survey responses.
Provide your patients with information on participating in clinical trials for PI.
USIDNET is a national registry of PI patients who have volunteered their medical information to help researchers answer important questions.
Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.
The Immune Deficiency Foundation improves the diagnosis, treatment, and quality of life for every person affected by primary immunodeficiency.
We foster a community that is connected, engaged, and empowered through advocacy, education, and research.
Combined Charity Campaign | CFC# 66309
